Nilogen Oncosystems - Company Profile

Nilogen is a developer of solutions for immuno-oncology drug development. It provides tumor platforms that offer powerful insight to guide drug development from beginning to end with 3D-Screen, 3D-EXplore, and 3D-EX. It uses assay technology for 3D image analysis that offers a visual and quantitative solution to drug efficacy in fresh patient toroids. It helps in real-time monitoring of proliferation, cell viability, and cell death 3D measurement of the volume. It also uses the tumor microenvironment technology that helps in adjusting tumor growth including numerous processes that promote tumorigenesis. The interactions involve many different cell types TME including tumor cells, fibroblasts, dendritic cells, TILs, macrophages, and NK cells as well as many noncellular components including the ECM and signaling molecules.